Medicared For All Logo

Jose Delgado-elvir MD in Ocala, Florida

Home Florida Ocala

Jose Delgado-elvir MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 3301 Sw34th Cir in Ocala, Florida.

They're a part of the: Pulmonary Consultants Of Ocala , Pllc medical group which has around 2 members. You can call their office at 352-237-2826 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1997 (around 27 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Jose Delgado-elvir MD Office Phone and Directions

Jose Delgado-elvir MD
Pulmonary Consultants Of Ocala , Pllc
3301 Sw34th Cir
Ocala, Florida 34474
352-237-2826


Patient Ratings
Please rate your experience with Jose Delgado-elvir MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 352-237-2826


Enter a starting address:


Healthcare Info for Jose Delgado-elvir MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Sorry, his university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Jose Delgado-elvir MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 3577576248
NPI #: 1093766768
NPI Created On: 05/15/2006
NPI Last Updated Listed as: 02/11/2015
Primary Taxonomy Code: 207RP1001X
License Number:
ME95387
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.


Services and Procedures include:

  1. Examination of lung airways using an endoscope
  2. Irrigation and suction of lung airways to obtain cells using an endoscope
  3. Computer-assisted image-guided navigation of lung airways using an endoscope
  4. Biopsy of one lobe of lung using an endoscope
  5. Insertion of central venous catheter for infusion, patient 5 years or older
  6. Measurement and graphic recording of total and timed exhaled air capacity
  7. Test for exercise-induced lung stress
  8. Determination of lung volumes using gas dilution or washout
  9. Measurement of lung diffusing capacity
  10. Sleep monitoring of patient (6 years or older) in sleep lab
  11. Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
  12. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  13. New patient office or other outpatient visit, typically 30 minutes
  14. New patient office or other outpatient visit, typically 45 minutes
  15. New patient office or other outpatient visit, typically 60 minutes
  16. Established patient office or other outpatient visit, typically 10 minutes
  17. Established patient office or other outpatient visit, typically 15 minutes
  18. Established patient office or other outpatient, visit typically 25 minutes
  19. Established patient office or other outpatient, visit typically 40 minutes
  20. Initial hospital inpatient care, typically 50 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787728131

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802730831

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802948919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803034517

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809572239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763645898

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0145-60


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763645900

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0145-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763645902

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: STIOLTO RESPIMAT

Open Associated Drug #1: 0597-0155-61


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851977419

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851734743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Pulmonary Disease Professionals in Ocala

1834 Sw 1st Ave
Ocala, FL
Ocala Lung And Critical Care Assocates Inc

1500 Sw 1st Ave
Ocala, FL
Appleton Intensivist Group, Llc

1500 Se 1st Ave
Ocala, FL
Appleton Intensivist Group, Llc

1500 Sw 1st Ave
Ocala, FL
Appleton Intensivist Group, Llc

1834 Sw 1st Ave
Ocala, FL
Ocala Lung And Critical Care Assocates Inc

1431 Sw 1st Ave
Ocala, FL
Intensive Care Consortium Inc

Providers in Pulmonary Consultants Of Ocala , Pllc

1.Lynnette Atkinson

3301 Sw34th Cir
Ocala Fl 34474-6620
Pulmonary Consultants Of Ocala , Pllc
Nurse Practitioner

2.Jose Delgado-elvir Md

3301 Sw34th Cir
Ocala Fl 34474-6620
Pulmonary Consultants Of Ocala , Pllc
Pulmonary Disease

View all 2 members of Pulmonary Consultants Of Ocala , Pllc medical group